| | Cancer | Skin Cancer
Psoriasis vs. Impetigo vs. Contact Dermatitis vs. Basal Cell Carcinoma: Comparison Guide
| Feature | Psoriasis | Impetigo | Contact Dermatitis | Basal Cell Carcinoma |
|---|---|---|---|---|
| Cause | Autoimmune (Th17/IL-23 axis); genetic + triggers | Bacterial (S. aureus, S. pyogenes) | Allergic (type IV) or irritant reaction | UV-driven mutations in basal keratinocytes (PTCH1, SMO) |
| Typical Lesions | Well-demarcated erythematous plaques with silvery scale; scalp, elbows, knees, sacrum | Honey-colored crusts on erythematous base; face, extremities | Pruritic erythema, vesicles, scaling; at exposure site | Pearly papule/nodule with telangiectasia; may ulcerate (rodent ulcer); sun-exposed areas |
| Distribution | Symmetrical, extensor surfaces, scalp, nails | Exposed areas, periorificial | Matches contact pattern (e.g., nickel at waistband) | Head/neck > trunk > extremities |
| Key Symptoms | Itch (variable), Auspitz sign, Koebner phenomenon | Mild itch, burning; contagious | Intense itch, burning | Often asymptomatic; may bleed |
| Diagnosis | Clinical; biopsy if atypical | Clinical; Gram stain/culture | Clinical; patch testing for allergens | Biopsy (shave/punch) |
| Treatment | Topicals (steroids, vit D analogs), phototherapy, systemics (methotrexate, biologics) | Topical mupirocin/retapamulin; oral cephalexin/doxycycline if extensive | Avoid trigger; topical steroids, calcineurin inhibitors; oral steroids if severe | Surgical excision (Mohs for high-risk), radiation, topical 5-FU/imiquimod (superficial) |
| Prognosis | Chronic, relapsing-remitting; controllable | Curable with antibiotics | Curable if allergen avoided | Highly curable if caught early; low metastatic potential |
Clinical Pearl
Any non-healing, growing, or changing skin lesion—especially on sun-exposed skin—warrants dermatology evaluation to rule out malignancy.
Skin Cancer - Related Articles
- Melanophages: Identity, Function & Clinical Relevance
- Sunbed Safety: Protecting Your Skin & Reducing Cancer Risk
- Melanoma: The Deadliest Skin Cancer—What You Need to Know
- Melanoma Origins: From Melanocytes to Malignancy
- Facial Skin Cancer Treatment Options & Procedures | [Your Clinic Name]
- Benign vs. Malignant Tumors: Key Distinguishing Features
- Aldara Cream and Skin Cancer: What You Need to Know
